These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1154 related articles for article (PubMed ID: 21747303)

  • 41. Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women.
    Yamauchi M; Yamaguchi T; Nawata K; Tanaka K; Takaoka S; Sugimoto T
    Endocrine; 2015 Feb; 48(1):279-86. PubMed ID: 24853884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
    Smilic TN; Novakovic TR; Markovic-Jovanovic SR; Smilic LLJ; Mitic JS; Radunovic ML
    J Clin Densitom; 2018; 21(3):322-328. PubMed ID: 29103946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring the Relationship of Bone Turnover Markers and Bone Mineral Density in Community-Dwelling Postmenopausal Women.
    Wei X; Zhang Y; Xiang X; Sun M; Sun K; Han T; Qi B; Xie Y; Zhang R; Zhu L
    Dis Markers; 2021; 2021():6690095. PubMed ID: 33968284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dexlansoprazole and Esomeprazole Do Not Affect Bone Homeostasis in Healthy Postmenopausal Women.
    Hansen KE; Nieves JW; Nudurupati S; Metz DC; Perez MC
    Gastroenterology; 2019 Mar; 156(4):926-934.e6. PubMed ID: 30445008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
    Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.
    Anastasilakis AD; Polyzos SA; Efstathiadou ZA; Savvidis M; Sakellariou GT; Papatheodorou A; Kokkoris P; Makras P
    Metabolism; 2015 Oct; 64(10):1291-7. PubMed ID: 26198440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-calcium, vitamin D fortified milk is effective in improving bone turnover markers and vitamin D status in healthy postmenopausal Chinese women.
    Kruger MC; Ha PC; Todd JM; Kuhn-Sherlock B; Schollum LM; Ma J; Qin G; Lau E
    Eur J Clin Nutr; 2012 Jul; 66(7):856-61. PubMed ID: 22644348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of genetic variants of vit D binding protein (DBP/GC) and of the enzyme catalyzing its 25-hydroxylation (DCYP2R1) and serum vit D in postmenopausal women.
    Xu W; Sun J; Wang W; Wang X; Jiang Y; Huang W; Zheng X; Wang Q; Ning Z; Pei Y; Nie M; Li M; Wang O; Xing X; Yu W; Lin Q; Xu L; Xia W
    Hormones (Athens); 2014; 13(3):345-52. PubMed ID: 25079458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
    Shou Z; Jin X; Bian P; Li X; Chen J
    Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone turnover markers and vitamin D status in postmenopausal Turkish women.
    Genç S; Ömer B; Aycan-Üstyol E; Kumral A; Gürdöl F
    Int J Vitam Nutr Res; 2012 Feb; 82(1):27-33. PubMed ID: 22811374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective.
    Kuchuk NO; van Schoor NM; Pluijm SM; Chines A; Lips P
    J Bone Miner Res; 2009 Apr; 24(4):693-701. PubMed ID: 19049341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relationship among serum lipocalin 2, bone turnover markers, and bone mineral density in outpatient women.
    Liu DM; Zhao HY; Zhao L; Zhang MJ; Liu TT; Tao B; Sun LH; Liu JM
    Endocrine; 2018 Feb; 59(2):304-310. PubMed ID: 29294226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between the metabolic syndrome and its components and bone status in postmenopausal women.
    Fodor D; Vesa S; Albu A; Simon S; Craciun A; Muntean L
    Acta Physiol Hung; 2014 Jun; 101(2):216-27. PubMed ID: 24901081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between basal metabolic function and bone metabolism in postmenopausal women with type 2 diabetes.
    Ogata M; Ide R; Takizawa M; Tanaka M; Tetsuo T; Sato A; Iwasaki N; Uchigata Y
    Nutrition; 2015; 31(11-12):1394-401. PubMed ID: 26429661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women.
    Kučukalić-Selimović E; Valjevac A; Hadžović-Džuvo A
    Bosn J Basic Med Sci; 2013 Nov; 13(4):259-65. PubMed ID: 24289763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials.
    Hernandez AV; Pérez-López FR; Piscoya A; Pasupuleti V; Roman YM; Thota P; Herrera A
    Maturitas; 2019 Nov; 129():12-22. PubMed ID: 31547908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relation of Age, Sex and Bone Mineral Density to Serum 25-Hydroxyvitamin D Levels in Chinese Women and Men.
    Wei QS; Chen ZQ; Tan X; Su HR; Chen XX; He W; Deng WM
    Orthop Surg; 2015 Nov; 7(4):343-9. PubMed ID: 26791959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of vitamin D status on the effect of statins on bone mineral density and bone turnover markers in postmenopausal women.
    Hernández JL; Olmos JM; Romaña G; Llorca J; Martínez J; Castillo J; de Juan J; Pérez-Pajares I; Ruiz S; González-Macías J
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3304-9. PubMed ID: 24878047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population.
    Jørgensen NR; Møllehave LT; Hansen YBL; Quardon N; Lylloff L; Linneberg A
    Osteoporos Int; 2017 Jul; 28(7):2103-2113. PubMed ID: 28455749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis.
    Lee DY; Jee JH; Cho YY; Jang JY; Yu TY; Kim TH; Hong YJ; Hong WJ; Jin SM; Hur KY; Kim JH; Kim SW; Chung JH; Lee MK; Min YK
    Osteoporos Int; 2017 Apr; 28(4):1377-1384. PubMed ID: 28188454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.